GlassScriptPhysician profile
Scott Christopher Pike
NPI 1417984071
$10,744.00
in general payments reported to CMS, 2019-2025
60 companies · $2,381 in 2025
The $2,381 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,269 · 2020: $435 · 2021: $116 · 2022: $1,517 · 2023: $1,621 · 2024: $3,404 · 2025: $2,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,178 · Travel and Lodging: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,178.24 |
| Travel and Lodging | $1,228.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,574.77 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $1,324.29 | 2019-2025 | Lithovue, Rezum Generator |
| Sumitomo Pharma America, INC. | $895.49 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $719.81 | 2019-2025 | |
| Janssen Biotech, INC. | $539.46 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $483.06 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $480.80 | 2019-2025 | |
| Accord Healthcare, INC. | $461.30 | 2022-2025 | |
| Abbvie INC. | $339.58 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $325.45 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Dendreon Pharmaceuticals LLC | $247.99 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $235.38 | 2019-2024 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $223.74 | 2019-2025 | Lynparza |
| Endo USA, INC. | $186.73 | 2024-2025 | Xiaflex, Aveed |
| Coloplast Corp | $180.84 | 2022-2024 | Speedicath |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $165.88 | 2019-2023 | Nocdurna, Xyosted, Tlando |
| Novartis Pharmaceuticals Corporation | $165.05 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $123.53 | 2019-2025 | Adstiladrin |
| Neotract INC. | $112.36 | 2019-2020 | |
| Dentsply Ih Ab | $107.02 | 2024-2025 | Lofric |
| Myriad Genetic Laboratories, INC. | $103.70 | 2021-2025 | Prolaris |
| Tolmar, INC. | $103.48 | 2023-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $100.08 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $91.47 | 2019-2023 | Yonsa |
| Rochester Medical Corporation | $88.75 | 2020 | |
| Amgen INC. | $87.91 | 2019-2021 | |
| Calyxo, INC. | $86.90 | 2024-2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $78.62 | 2020-2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Genzyme Corporation | $72.73 | 2022-2023 | |
| Teleflex LLC | $66.04 | 2023-2025 | Urolift, Barrigel |
| Myovant Sciences INC. | $64.89 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $62.75 | 2023-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $62.27 | 2019-2022 | |
| Halozyme INC | $51.51 | 2023 | |
| Blue Earth Diagnostics | $51.09 | 2019 | |
| Urovant Sciences INC | $45.57 | 2022 | |
| Cardinal Health 108 LLC | $45.18 | 2024 | |
| Foundation Medicine, INC. | $44.22 | 2020-2023 | |
| Immunitybio, INC. | $43.85 | 2024-2025 | |
| Srs Medical Systems, INC. | $42.61 | 2023 | Urocuff |
| Civco Medical Instruments | $40.87 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $40.01 | 2020 | |
| Allergan, INC. | $39.46 | 2019 | |
| Verity Pharmaceuticals INC. | $38.84 | 2024-2025 | Trelstar |
| Cycle Pharmaceuticals INC | $35.15 | 2025 | Venxxiva |
| Hollister Incorporated | $23.46 | 2023 | Vapro Plus Pocket, Infyna Chic |
| Travere Therapeutics, INC. | $22.44 | 2020 | |
| Kci USA, INC. | $22.12 | 2020 | |
| Alnylam Pharmaceuticals INC. | $21.79 | 2023 | Givlaari |
| Ethicon US, LLC | $21.56 | 2019 | |
| Medtronic, INC. | $21.18 | 2023 | Interstim |
| Gilead Sciences, INC. | $19.98 | 2025 | |
| Aytu Biopharma, INC. | $17.46 | 2019 | |
| Novo Nordisk INC | $15.91 | 2024 | Rivfloza |
| Medtronic USA, INC. | $14.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.09 | 2019 | |
| Mission Pharmacal Company | $14.00 | 2023 | Lithostat |
| Axonics, INC. | $11.88 | 2022 | |
| Edap Technomed INC | $11.83 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.